Refine
Document Type
- Article (4)
- Doctoral Thesis (1)
Language
- English (5)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- - (4)
- periodontitis (3)
- Bose-Einstein-Kondensation (1)
- C-reactive protein (1)
- Cyclooxygenase-2 (1)
- Exziton (1)
- GATA-3 (1)
- Interleukin-1 (1)
- Interleukin-4 (1)
- Polaron (1)
Institute
Publisher
- IOP Publishing (1)
- MDPI (1)
- SAGE Publications (1)
Periodontitis is a multifactorial disease. The aim of this explorative study was to investigate the role of Interleukin-(IL)-1, IL-4, GATA-3 and Cyclooxygenase-(COX)-2 polymorphisms after non-surgical periodontal therapy with adjunctive systemic antibiotics (amoxicillin/metronidazole) and subsequent maintenance in a Caucasian population. Analyses were performed using blood samples from periodontitis patients of a multi-center trial (ClinicalTrials.gov NCT00707369=ABPARO-study). Polymorphisms were analyzed using quantitative real-time PCR. Clinical attachment levels (CAL), percentage of sites showing further attachment loss (PSAL) ≥1.3 mm, bleeding on probing (BOP) and plaque score were assessed. Exploratory statistical analysis was performed. A total of 209 samples were genotyped. Patients carrying heterozygous genotypes and single-nucleotide-polymorphisms (SNP) on the GATA-3-IVS4 +1468 gene locus showed less CAL loss than patients carrying wild type. Heterozygous genotypes and SNPs on the IL-1A-889, IL-1B +3954, IL-4-34, IL-4-590, GATA-3-IVS4 +1468 and COX-2-1195 gene loci did not influence CAL. In multivariate analysis, CAL was lower in patients carrying GATA-3 heterozygous genotypes and SNPs than those carrying wild-types. For the first time, effects of different genotypes were analyzed in periodontitis progression after periodontal therapy and during supportive treatment using systemic antibiotics demonstrating a slight association of GATA-3 gene locus with CAL. This result suggests that GATA-3 genotypes are a contributory but non-essential risk factor for periodontal disease progression.
Nanoengineering and laser optics allow for the fabrication of a wide range of systems that subject fermionic particles to geometric restrictions. In addition to strong correlations, the fermions may couple to internal or external bosonic fields, such as quantized lattice vibrations or light fields. This thesis considers the theoretical description of two such systems. One is a molecular junction, i.e., a small organic molecule contacted by metallic electrodes or leads. Itinerant electrons induce molecular vibrations and deformations, corresponding to phonon modes of considerable energy. The thesis investigates the effects of this local electron-phonon interaction on the electric and thermoelectric transport through the junction. Starting with an Anderson-Holstein quantum dot model, our ansatz is based on the application of a variational Lang-Firsov transformation that accounts for the polaronic character of the dot state. We solve the steady-state Kadanoff-Baym equations and derive a self-consistent approximation to the polaronic self-energy that accounts for finite densities and multi-phonon scattering processes. The optimal variational parameter is determined numerically by minimizing the thermodynamical potential. This allows a detailed study of the electronic dot spectral function for all interaction strengths and adiabaticity regimes. For instance, we discuss how a voltage dependent polaronic renormalization of the dot-lead coupling and the dot level causes negative differential conductance and novel conductance features. The investigation of the second system is motivated by recent experiments on the Bose-Einstein condensation of excitons in small semiconducting cuprous oxide crystals. At ultra cold temperatures three species of para- and orthoexcitons are caught in stress induced potential traps. Their decay luminescence is the primary method of detection. This thesis considers the thermodynamics of this system in terms of a multicomponent gas of weakly interacting bosons in external potentials. The coupled equations of motion are solved within a Hartree-Fock-Bogoliubov-Popov approximation. For typical experimental parameters the density distributions of the interacting species are calculated numerically. Based on the luminescence formula by Shi and Verechaka we discuss, e.g., how the spectrum of the direct decay of thermal paraexcitons may reveal the formation of a nonluminescent paraexciton condensate as well as the spatial separation of strongly repulsive orthocondensates. First results for an extended luminescence theory are presented, which takes into account the polariton effect.
Evidence is limited regarding whether periodontal treatment improves hemoglobin A1c (HbA1c) among people with prediabetes and periodontal disease, and it is unknown whether improvement of metabolic status persists >3 mo. In an exploratory post hoc analysis of the multicenter randomized controlled trial “Antibiotika und Parodontitis” (Antibiotics and Periodontitis)—a prospective, stratified, double-blind study—we assessed whether nonsurgical periodontal treatment with or without an adjunctive systemic antibiotic treatment affects HbA1c and high-sensitivity C-reactive protein (hsCRP) levels among periodontitis patients with normal HbA1c (≤5.7%, n = 218), prediabetes (5.7% < HbA1c < 6.5%, n = 101), or unknown diabetes (HbA1c ≥ 6.5%, n = 8) over a period of 27.5 mo. Nonsurgical periodontal treatment reduced mean pocket probing depth by >1 mm in both groups. In the normal HbA1c group, HbA1c values remained unchanged at 5.0% (95% CI, 4.9% to 6.1%) during the observation period. Among periodontitis patients with prediabetes, HbA1c decreased from 5.9% (95% CI, 5.9% to 6.0%) to 5.4% (95% CI, 5.3% to 5.5%) at 15.5 mo and increased to 5.6% (95% CI, 5.4% to 5.7%) after 27.5 mo. At 27.5 mo, 46% of periodontitis patients with prediabetes had normal HbA1c levels, whereas 47.9% remained unchanged and 6.3% progressed to diabetes. Median hsCRP values were reduced in the normal HbA1c and prediabetes groups from 1.2 and 1.4 mg/L to 0.7 and 0.7 mg/L, respectively. Nonsurgical periodontal treatment may improve blood glucose values among periodontitis patients with prediabetes (ClinicalTrials.gov NCT00707369).
Abstract
Aim
The aim of this study was to evaluate the effect of non‐surgical periodontal therapy on circulating levels of the systemic inflammation‐associated biomarkers orosomucoid (ORM), high‐sensitivity C‐reactive protein (hsCRP), chemerin, and retinol‐binding protein 4 (RBP4) in overweight or normal‐weight patients with periodontitis at 27.5 months after therapy.
Materials and methods
This exploratory subanalysis includes patients from the ABPARO‐trial (ClinicalTrials.gov NCT00707369). The per‐protocol collective provided untreated periodontitis patients with high (≥28 kg/m2) or moderate (21–24 kg/m2) BMI. Out of the per‐protocol collective, 80 patients were randomly selected and stratified for BMI group, sex, and treatment group (antibiotics/placebo), resulting in 40 overweight and normal‐weight patients. Patients received non‐surgical periodontal therapy and maintenance at 3‐month intervals. Plasma samples from baseline and 27.5 months following initial treatment were used to measure the concentrations of ORM, hsCRP, chemerin, and RBP4.
Results
At the 27.5‐month examination, ORM and hsCRP decreased noticeably in the overweight group (ORM: p = .001, hsCRP: p = .004) and normal‐weight patients (ORM: p = .007, hsCRP: p < .001). Chemerin decreased in the overweight group (p = .048), and RBP4 concentrations remained stable.
Conclusion
Non‐surgical periodontal therapy reduced systemically elevated inflammation‐associated biomarkers in periodontitis patients. These improvements were more pronounced in overweight patients than in normal‐weight patients.
Abstract
We present experiments on the luminescence of excitons confined in a potential trap at milli-Kelvin bath temperatures under continuous-wave (cw) excitation. They reveal several distinct features like a kink in the dependence of the total integrated luminescence intensity on excitation laser power and a bimodal distribution of the spatially resolved luminescence. Furthermore, we discuss the present state of the theoretical description of Bose–Einstein condensation of excitons with respect to signatures of a condensate in the luminescence. The comparison of the experimental data with theoretical results with respect to the spatially resolved as well as the integrated luminescence intensity shows the necessity of taking into account a Bose–Einstein condensed excitonic phase in order to understand the behaviour of the trapped excitons.